Arkolith/Insider Trading/ALMR/Form 4

McAnear Justin J.

Chief Financial OfficerAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Grant(A)37K—$037K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)571K—$00
Apr 20, 2026Other(J)571K—$0571K
Apr 16, 2026Grant(A)163K—$0163K

Transaction Codes

A
Grant / award
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001786386-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML